Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
Conditions
Acute Myeloid Leukemia (AML) in Remission · Stem Cell Transplantation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
L'Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Brussels, Belgium
Contact: Study coordinator (Pauline Mazilier, MD, PhD) · Pauline.mazilier@huderf.bf · 0032 2 477 26 78Contact: Principal Investigator (Pauline Mazilier, MD, PhD)Cliniques Universitaires Saint-Luc (CUSL), Brussels, Belgium
Contact: Study coordinator (Cécile Boulanger, MD, PhD)Contact: Principal Investigator (Cécile Boulanger, MD, PhD)Department of Pediatric Hematology, Oncology and SCT, Ghent University Hospital, Ghent, Belgium
Contact: Study coordinator (Victoria Bordon, MD, PhD) · Victoria.Bordon@uzgent.be · 0032 9 332 58 60Contact: Principal Investigator (Victoria Bordon, MD, PhD)University Hospital Leuven, Leuven, Belgium
Contact: Study coordinator (Anne Uyttebroeck, MD, PhD) · Anne.uyttebroeck@uzleuven.be · 0032 16 34 39 72Contact: Principal Investigator (Anne Uyttebroeck, MD, PhD)Centre Hospitalier Régional de la Citadelle (CHR)/CHU Liège, Liège, Belgium
Contact: Principal Investigator (Evelyne Willems, MD, PhD)Paediatric Stem Cell Transplant and Immune Deficiency, Department of Pediatric and Adolescent Medicine, Section 4072, Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark
Contact: Study coordinator (Marianne Ifversen, MD, PhD) · Marianne.Ifversen@regionh.dk · +45 3545 0979Contact: Principal Investigator (Marianne Ifversen, MD, PhD)Division of Hematology, Oncology, and Stem Cell Transplantation, The New Children's Hospital, Helsinki University Hospital, Helsinki, Finland
Contact: Principal Investigator (Samppa Ryhänen, MD, PhD)Department of Pediatrics and Adolescent Medicine, Hong King Children's Hospital, Hong Kong, Hong Kong
Contact: Principal Investigator (Daniel Cheuk, MD, PhD)Schneider Children's Medical Center of Israel, Petah Tikva, Israel
Contact: Principal Investigator (Jerry Stein, MD, PhD)Vilnius University Hospital Santaros Klinikos Center for Pediatric Oncology and Hematology, Vilnius, Lithuania
Contact: Principal Investigator (Jelena Rascon, MD, PhD)Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
Contact: Study coordinator (Birgitta Versluys, MD, PhD) · A.B.Versluijs@prinsesmaximacentrum.nl · +31650006514Contact: Principal Investigator (Birgitta Versluys, MD, PhD)Department of Pediatric Hematology and Oncology, Oslo University HospitalOslo University Hospital, Oslo, Norway
Contact: Principal Investigator (Jochen Buechner, MD, PhD)Stemcelltransplant unit Hospital Niño Jesús, Madrid, Spain
Contact: Study coordinator (Marta Gonzales Vicent Gonzales Vicent, MD, PhD) · martagonzalesvicent@gmail.com · +34-915035938Contact: Principal Investigator (José M Fernandez, MD, PhD)Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden
Contact: Study coordinator (Karin Mellgren, Prof.MD) · karin.mellgren@vgregion.se · +46 (0)31 3421000Contact: Principal Investigator (Cecilia Langenskiöld, MD, PhD)Barncancercentrum, avdelning 64, Skane University Hospital, Lund, Sweden
Contact: Principal Investigator (Kees-Jan Pronk, MD, PhD)Dominik Turkiewicz, MD, PhD (Sub-investigator)Pediatric Hematology immunology and stem cell transplantation Astrid Lindgren children's Hospital Huddinge K86-88, Stockholm, Sweden
Contact: Principal Investigator (Mikael Sundin, MD, PhD)Childrens department for Blood and tumor diseases Uppsala University Hospital, Uppsala, Sweden
Contact: Principal Investigator (Natalja Jackmann, MD, PhD)
Study leads
Karin Mellgren, Prof. MD
Study Chair
Sahlgrenska University Hospital
Birgitta Versluys, MD, Phd
Principal Investigator
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands